Advertisement
Inogen, Inc.

Inogen, Inc. (INGN) Stock Overview

Explore Inogen, Inc.’s financial performance, market position, analyst ratings, and future outlook.

INGNNASDAQ
HealthcareMedical - Devices
$6.94
$0.16(2.36%)
U.S. Market opens in 54h 49m
Advertisement

Inogen, Inc. (INGN)

Meyka AI Score

Z

Key Financials

Market Cap187.9M
P/E Ratio-7.46
EPS (TTM)$-0.91
ROE-0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$6.23
3 Months$9.05
1 Year Target$5.38

INGN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Inogen, Inc. (INGN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.42, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.38.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.46 and a market capitalization of 187.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.36%
5-Day Change
8.44%
1-Month Change
5.47%
3-Month Change
6.77%
6-Month Change
2.06%
Year-to-Date (YTD) Change
3.27%
1-Year Change
-3.61%
3-Year Change
-37.65%
5-Year Change
-89.54%
All-Time (Max) Change
-54.19%

Contact Information

805 562 0500
301 Coromar Drive, Goleta, CA, 93117

Company Facts

7,660 Employees
IPO DateFeb 14, 2014
CountryUS
Actively Trading

Frequently Asked Questions